Original data (with adjusted standard errors for multi-arm studies):

              treat1      treat2      TE   seTE seTE.adj.f seTE.adj.r narms multiarm
3   BZD-intermediate   BZD-short -0.0599 0.7239     0.7239     0.7239     2         
6        eszopiclone     placebo  1.0074 0.6848     0.6848     0.6848     2         
10           placebo    zolpidem  1.1919 0.6674     0.6674     0.6674     2         
11  BZD-intermediate    BZD-long -1.1186 1.6452     1.6452     1.6452     2         
16          BZD-long   BZD-short -0.1246 0.4997     0.4997     0.4997     2         
18  BZD-intermediate     placebo -0.5596 0.7356     0.7356     0.7356     2         
23  BZD-intermediate    BZD-long -0.8011 0.7792     0.8044     0.8044     3        *
23  BZD-intermediate     placebo  1.6219 1.5572     2.5870     2.5870     3        *
23          BZD-long     placebo  2.4231 1.4856     1.7765     1.7765     3        *
32           placebo    zaleplon  0.3104 0.4246     0.5363     0.5363     3        *
32          zaleplon    zolpidem -0.8566 0.3789     0.4367     0.4367     3        *
32           placebo    zolpidem -0.5462 0.4261     0.5410     0.5410     3        *
37          BZD-long   BZD-short -0.0495 0.1803     0.2836     0.2836     4        *
37          BZD-long     placebo  0.0547 0.1836     0.2943     0.2943     4        *
37          BZD-long   zopiclone  0.0498 0.1583     0.2052     0.2052     4        *
37         BZD-short     placebo  0.1041 0.1801     0.2831     0.2831     4        *
37         BZD-short   zopiclone  0.0993 0.1543     0.1973     0.1973     4        *
37           placebo   zopiclone -0.0049 0.1581     0.2048     0.2048     4        *
39           placebo    zolpidem -1.2674 0.5797     0.5797     0.5797     2         
45           placebo  suvorexant -0.1005 0.4719     0.4719     0.4719     2         
46           placebo  suvorexant -0.3530 0.5242     0.5242     0.5242     2         
48          zaleplon    zolpidem -0.9768 0.4450     0.4450     0.4450     2         
49          zaleplon    zolpidem  0.4520 0.9625     0.9625     0.9625     2         
57          BZD-long   zopiclone -1.1256 1.6495     1.6495     1.6495     2         
58       eszopiclone     placebo  1.2297 0.4371     0.4371     0.4371     2         
59           placebo    zolpidem -0.8979 0.4226     0.4226     0.4226     2         
62           placebo    zolpidem -0.1900 1.0210     1.0210     1.0210     2         
63           doxepin     placebo  1.5778 1.5543     1.5543     1.5543     2         
77       eszopiclone     placebo  1.4962 0.7918     0.7918     0.7918     2         
87           placebo    zolpidem  1.3669 1.2121     1.2121     1.2121     2         
99      daridorexant    zolpidem -1.0330 0.7808     0.8365     0.8365     3        *
99           placebo    zolpidem -1.4385 1.1335     1.4428     1.4428     3        *
99      daridorexant     placebo  0.4055 1.1657     1.6299     1.6299     3        *
106      eszopiclone   zopiclone  0.6419 0.3863     0.3863     0.3863     2         
114          placebo    zolpidem -0.8377 0.5203     0.5203     0.5203     2         
115          placebo   ramelteon -0.2648 0.3270     0.3270     0.3270     2         
117       doxylamine    zolpidem -0.6483 0.8763     1.1294     1.1294     3        *
117          placebo    zolpidem  0.0822 0.7199     0.8063     0.8063     3        *
117       doxylamine     placebo -0.7305 0.8768     1.1311     1.1311     3        *
119          placebo    zolpidem -1.9876 1.5392     1.5392     1.5392     2         
127          placebo   ramelteon -1.9459 1.5132     1.5132     1.5132     2         
133        BZD-short    zaleplon  0.8168 0.7887     0.8183     0.8183     3        *
133          placebo    zaleplon -1.3202 1.5265     2.0580     2.0580     3        *
133        BZD-short     placebo  2.1370 1.5329     2.1238     2.1238     3        *
137          placebo    zolpidem -1.1047 0.6921     0.6921     0.6921     2         
144      eszopiclone     placebo -0.0563 0.6249     0.6249     0.6249     2         
145          placebo   ramelteon  0.0616 0.6445     0.6445     0.6445     2         
146      eszopiclone   zopiclone  0.1542 0.5720     0.5720     0.5720     2         
149 BZD-intermediate   trazodone  0.5921 1.2380     1.2380     1.2380     2         
153      lemborexant    zolpidem -1.2016 0.5752     0.6580     0.6580     3        *
153          placebo    zolpidem -0.4700 0.6195     0.7393     0.7393     3        *
153      lemborexant     placebo -0.7316 0.6759     0.9252     0.9252     3        *
154      lemborexant     placebo -0.6547 0.9311     0.9311     0.9311     2         
158          placebo seltorexant  2.1654 1.6385     3.1025     3.1025     3        *
158          placebo    zolpidem -1.3832 0.9362     0.9712     0.9712     3        *
158      seltorexant    zolpidem -3.5487 1.4836     1.6673     1.6673     3        *
159     daridorexant     placebo  1.1934 0.7628     0.7628     0.7628     2         
160     daridorexant     placebo  0.4088 0.6506     0.6506     0.6506     2         
164 BZD-intermediate mirtazapine -1.0986 1.1799     1.1799     1.1799     2         
166 BZD-intermediate mirtazapine  0.3567 0.5544     0.5544     0.5544     2         

Number of treatment arms (by study):
    narms
3       2
6       2
10      2
11      2
16      2
18      2
23      3
32      3
37      4
39      2
45      2
46      2
48      2
49      2
57      2
58      2
59      2
62      2
63      2
77      2
87      2
99      3
106     2
114     2
115     2
117     3
119     2
127     2
133     3
137     2
144     2
145     2
146     2
149     2
153     3
154     2
158     3
159     2
160     2
164     2
166     2

Results (fixed effects model):

              treat1      treat2      OR             95%-CI    Q leverage
3   BZD-intermediate   BZD-short  0.5983 [0.2599;   1.3774] 0.39     0.35
6        eszopiclone     placebo  2.1642 [1.3872;   3.3764] 0.12     0.11
10           placebo    zolpidem  0.5393 [0.3839;   0.7576] 7.35     0.07
11  BZD-intermediate    BZD-long  0.6260 [0.2716;   1.4429] 0.16     0.07
16          BZD-long   BZD-short  0.9558 [0.6903;   1.3235] 0.03     0.11
18  BZD-intermediate     placebo  0.7114 [0.3088;   1.6387] 0.09     0.34
23  BZD-intermediate    BZD-long  0.6260 [0.2716;   1.4429] 0.17        .
23  BZD-intermediate     placebo  0.7114 [0.3088;   1.6387] 0.58        .
23          BZD-long     placebo  1.1364 [0.8107;   1.5930] 1.67        .
32           placebo    zaleplon  1.2456 [0.7288;   2.1291] 0.03        .
32          zaleplon    zolpidem  0.4329 [0.2642;   0.7093] 0.00        .
32           placebo    zolpidem  0.5393 [0.3839;   0.7576] 0.02        .
37          BZD-long   BZD-short  0.9558 [0.6903;   1.3235] 0.00        .
37          BZD-long     placebo  1.1364 [0.8107;   1.5930] 0.06        .
37          BZD-long   zopiclone  1.0438 [0.7747;   1.4064] 0.00        .
37         BZD-short     placebo  1.1890 [0.8564;   1.6508] 0.06        .
37         BZD-short   zopiclone  1.0921 [0.8167;   1.4604] 0.00        .
37           placebo   zopiclone  0.9185 [0.6895;   1.2236] 0.15        .
39           placebo    zolpidem  0.5393 [0.3839;   0.7576] 1.26     0.09
45           placebo  suvorexant  0.8078 [0.4062;   1.6062] 0.06     0.55
46           placebo  suvorexant  0.8078 [0.4062;   1.6062] 0.07     0.45
48          zaleplon    zolpidem  0.4329 [0.2642;   0.7093] 0.10     0.32
49          zaleplon    zolpidem  0.4329 [0.2642;   0.7093] 1.79     0.07
57          BZD-long   zopiclone  1.0438 [0.7747;   1.4064] 0.50     0.01
58       eszopiclone     placebo  2.1642 [1.3872;   3.3764] 1.10     0.27
59           placebo    zolpidem  0.5393 [0.3839;   0.7576] 0.44     0.17
62           placebo    zolpidem  0.5393 [0.3839;   0.7576] 0.18     0.03
63           doxepin     placebo  4.8444 [0.2303; 101.9177] 0.00     1.00
77       eszopiclone     placebo  2.1642 [1.3872;   3.3764] 0.84     0.08
87           placebo    zolpidem  0.5393 [0.3839;   0.7576] 2.68     0.02
99      daridorexant    zolpidem  0.8353 [0.3578;   1.9499] 1.04        .
99           placebo    zolpidem  0.5393 [0.3839;   0.7576] 0.32        .
99      daridorexant     placebo  1.5489 [0.6877;   3.4887] 0.00        .
106      eszopiclone   zopiclone  1.9878 [1.2645;   3.1249] 0.01     0.36
114          placebo    zolpidem  0.5393 [0.3839;   0.7576] 0.18     0.11
115          placebo   ramelteon  0.7706 [0.4396;   1.3507] 0.00     0.77
117       doxylamine    zolpidem  0.3687 [0.0763;   1.7823] 0.10        .
117          placebo    zolpidem  0.5393 [0.3839;   0.7576] 0.75        .
117       doxylamine     placebo  0.6838 [0.1415;   3.3053] 0.10        .
119          placebo    zolpidem  0.5393 [0.3839;   0.7576] 0.79     0.01
127          placebo   ramelteon  0.7706 [0.4396;   1.3507] 1.24     0.04
133        BZD-short    zaleplon  1.4811 [0.8054;   2.7236] 0.27        .
133          placebo    zaleplon  1.2456 [0.7288;   2.1291] 0.56        .
133        BZD-short     placebo  1.1890 [0.8564;   1.6508] 0.86        .
137          placebo    zolpidem  0.5393 [0.3839;   0.7576] 0.50     0.06
144      eszopiclone     placebo  2.1642 [1.3872;   3.3764] 1.76     0.13
145          placebo   ramelteon  0.7706 [0.4396;   1.3507] 0.25     0.20
146      eszopiclone   zopiclone  1.9878 [1.2645;   3.1249] 0.87     0.16
149 BZD-intermediate   trazodone  1.8077 [0.1597;  20.4617] 0.00     1.00
153      lemborexant    zolpidem  0.2847 [0.1127;   0.7190] 0.01        .
153          placebo    zolpidem  0.5393 [0.3839;   0.7576] 0.04        .
153      lemborexant     placebo  0.5279 [0.2090;   1.3331] 0.01        .
154      lemborexant     placebo  0.5279 [0.2090;   1.3331] 0.00     0.26
158          placebo seltorexant 15.7922 [0.8771; 284.3306] 0.04        .
158          placebo    zolpidem  0.5393 [0.3839;   0.7576] 0.62        .
158      seltorexant    zolpidem  0.0341 [0.0019;   0.6081] 0.01        .
159     daridorexant     placebo  1.5489 [0.6877;   3.4887] 0.98     0.30
160     daridorexant     placebo  1.5489 [0.6877;   3.4887] 0.00     0.41
164 BZD-intermediate mirtazapine  1.0980 [0.4107;   2.9357] 1.02     0.18
166 BZD-intermediate mirtazapine  1.0980 [0.4107;   2.9357] 0.23     0.82

Results (random effects model):

              treat1      treat2      OR             95%-CI
3   BZD-intermediate   BZD-short  0.5983 [0.2599;   1.3774]
6        eszopiclone     placebo  2.1642 [1.3872;   3.3764]
10           placebo    zolpidem  0.5393 [0.3839;   0.7576]
11  BZD-intermediate    BZD-long  0.6260 [0.2716;   1.4429]
16          BZD-long   BZD-short  0.9558 [0.6903;   1.3235]
18  BZD-intermediate     placebo  0.7114 [0.3088;   1.6387]
23  BZD-intermediate    BZD-long  0.6260 [0.2716;   1.4429]
23  BZD-intermediate     placebo  0.7114 [0.3088;   1.6387]
23          BZD-long     placebo  1.1364 [0.8107;   1.5930]
32           placebo    zaleplon  1.2456 [0.7288;   2.1291]
32          zaleplon    zolpidem  0.4329 [0.2642;   0.7093]
32           placebo    zolpidem  0.5393 [0.3839;   0.7576]
37          BZD-long   BZD-short  0.9558 [0.6903;   1.3235]
37          BZD-long     placebo  1.1364 [0.8107;   1.5930]
37          BZD-long   zopiclone  1.0438 [0.7747;   1.4064]
37         BZD-short     placebo  1.1890 [0.8564;   1.6508]
37         BZD-short   zopiclone  1.0921 [0.8167;   1.4604]
37           placebo   zopiclone  0.9185 [0.6895;   1.2236]
39           placebo    zolpidem  0.5393 [0.3839;   0.7576]
45           placebo  suvorexant  0.8078 [0.4062;   1.6062]
46           placebo  suvorexant  0.8078 [0.4062;   1.6062]
48          zaleplon    zolpidem  0.4329 [0.2642;   0.7093]
49          zaleplon    zolpidem  0.4329 [0.2642;   0.7093]
57          BZD-long   zopiclone  1.0438 [0.7747;   1.4064]
58       eszopiclone     placebo  2.1642 [1.3872;   3.3764]
59           placebo    zolpidem  0.5393 [0.3839;   0.7576]
62           placebo    zolpidem  0.5393 [0.3839;   0.7576]
63           doxepin     placebo  4.8444 [0.2303; 101.9177]
77       eszopiclone     placebo  2.1642 [1.3872;   3.3764]
87           placebo    zolpidem  0.5393 [0.3839;   0.7576]
99      daridorexant    zolpidem  0.8353 [0.3578;   1.9499]
99           placebo    zolpidem  0.5393 [0.3839;   0.7576]
99      daridorexant     placebo  1.5489 [0.6877;   3.4887]
106      eszopiclone   zopiclone  1.9878 [1.2645;   3.1249]
114          placebo    zolpidem  0.5393 [0.3839;   0.7576]
115          placebo   ramelteon  0.7706 [0.4396;   1.3507]
117       doxylamine    zolpidem  0.3687 [0.0763;   1.7823]
117          placebo    zolpidem  0.5393 [0.3839;   0.7576]
117       doxylamine     placebo  0.6838 [0.1415;   3.3053]
119          placebo    zolpidem  0.5393 [0.3839;   0.7576]
127          placebo   ramelteon  0.7706 [0.4396;   1.3507]
133        BZD-short    zaleplon  1.4811 [0.8054;   2.7236]
133          placebo    zaleplon  1.2456 [0.7288;   2.1291]
133        BZD-short     placebo  1.1890 [0.8564;   1.6508]
137          placebo    zolpidem  0.5393 [0.3839;   0.7576]
144      eszopiclone     placebo  2.1642 [1.3872;   3.3764]
145          placebo   ramelteon  0.7706 [0.4396;   1.3507]
146      eszopiclone   zopiclone  1.9878 [1.2645;   3.1249]
149 BZD-intermediate   trazodone  1.8077 [0.1597;  20.4617]
153      lemborexant    zolpidem  0.2847 [0.1127;   0.7190]
153          placebo    zolpidem  0.5393 [0.3839;   0.7576]
153      lemborexant     placebo  0.5279 [0.2090;   1.3331]
154      lemborexant     placebo  0.5279 [0.2090;   1.3331]
158          placebo seltorexant 15.7922 [0.8771; 284.3306]
158          placebo    zolpidem  0.5393 [0.3839;   0.7576]
158      seltorexant    zolpidem  0.0341 [0.0019;   0.6081]
159     daridorexant     placebo  1.5489 [0.6877;   3.4887]
160     daridorexant     placebo  1.5489 [0.6877;   3.4887]
164 BZD-intermediate mirtazapine  1.0980 [0.4107;   2.9357]
166 BZD-intermediate mirtazapine  1.0980 [0.4107;   2.9357]

Number of studies: k = 41
Number of pairwise comparisons: m = 60
Number of observations: o = 15128
Number of treatments: n = 17
Number of designs: d = 24

Fixed effects model

Treatment estimate (sm = 'OR', comparison: other treatments vs 'BZD-intermediate'):
                     OR             95%-CI     z p-value
BZD-intermediate      .                  .     .       .
BZD-long         1.5975 [0.6931;   3.6823]  1.10  0.2716
BZD-short        1.6714 [0.7260;   3.8478]  1.21  0.2273
daridorexant     2.1773 [0.6798;   6.9731]  1.31  0.1901
doxepin          6.8098 [0.2893; 160.2827]  1.19  0.2339
doxylamine       0.9612 [0.1617;   5.7141] -0.04  0.9653
eszopiclone      3.0423 [1.2022;   7.6990]  2.35  0.0188
lemborexant      0.7421 [0.2134;   2.5800] -0.47  0.6389
mirtazapine      0.9108 [0.3406;   2.4351] -0.19  0.8522
placebo          1.4057 [0.6102;   3.2382]  0.80  0.4238
ramelteon        1.8242 [0.6673;   4.9868]  1.17  0.2413
seltorexant      0.0890 [0.0044;   1.8026] -1.58  0.1150
suvorexant       1.7403 [0.5903;   5.1302]  1.00  0.3152
trazodone        0.5532 [0.0489;   6.2617] -0.48  0.6325
zaleplon         1.1285 [0.4211;   3.0241]  0.24  0.8100
zolpidem         2.6067 [1.0607;   6.4063]  2.09  0.0368
zopiclone        1.5305 [0.6595;   3.5516]  0.99  0.3218

Random effects model

Treatment estimate (sm = 'OR', comparison: other treatments vs 'BZD-intermediate'):
                     OR             95%-CI     z p-value
BZD-intermediate      .                  .     .       .
BZD-long         1.5975 [0.6931;   3.6823]  1.10  0.2716
BZD-short        1.6714 [0.7260;   3.8478]  1.21  0.2273
daridorexant     2.1773 [0.6798;   6.9731]  1.31  0.1901
doxepin          6.8098 [0.2893; 160.2827]  1.19  0.2339
doxylamine       0.9612 [0.1617;   5.7141] -0.04  0.9653
eszopiclone      3.0423 [1.2022;   7.6990]  2.35  0.0188
lemborexant      0.7421 [0.2134;   2.5800] -0.47  0.6389
mirtazapine      0.9108 [0.3406;   2.4351] -0.19  0.8522
placebo          1.4057 [0.6102;   3.2382]  0.80  0.4238
ramelteon        1.8242 [0.6673;   4.9868]  1.17  0.2413
seltorexant      0.0890 [0.0044;   1.8026] -1.58  0.1150
suvorexant       1.7403 [0.5903;   5.1302]  1.00  0.3152
trazodone        0.5532 [0.0489;   6.2617] -0.48  0.6325
zaleplon         1.1285 [0.4211;   3.0241]  0.24  0.8100
zolpidem         2.6067 [1.0607;   6.4063]  2.09  0.0368
zopiclone        1.5305 [0.6595;   3.5516]  0.99  0.3218

Quantifying heterogeneity / inconsistency:
tau^2 = 0; tau = 0; I^2 = 0% [0.0%; 38.3%]

Tests of heterogeneity (within designs) and inconsistency (between designs):
                    Q d.f. p-value
Total           32.43   34  0.5448
Within designs  22.65   17  0.1611
Between designs  9.78   17  0.9126
[1] "A total of 17 treatments are included in the network."
[1] "A total of 41 studies are included in this analysis."
[1] "A total of 15128 participants are included in this analysis, with 986 events (6.52%)."
[1] "The following studies were included in this analysis: 3 6 10 11 16 18 23 32 37 39 45 46 48 49 57 58 59 62 63 77 87 99 106 114 115 117 119 127 133 137 144 145 146 149 153 154 158 159 160 164 166"
[1] "Estimated heterogeneity tau-squared0"
[1] "Global test for inconsistency, p-value 0.91257 (Q=10, d.o.f. 17)"
[1] "File created on 2022-04-06"
